AAUM (Average Assets Under Management) of ₹231.97 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 71.3% | 70.4% | ▼ -0.9% |
| Healthcare Services | 19.6% | 20.6% | ▲ +1.1% |
| Industrial Products | 2.3% | 2.2% | ▼ -0.1% |
| Healthcare Equipment & Supplies | 0.7% | 1.3% | ▲ +0.6% |
| Chemicals & Petrochemicals | 2.4% | 1.3% | ▼ -1.2% |
| Aerospace & Defense | 0.0% | 0.5% | ▲ +0.5% |
| Banks | 0.5% | 0.5% | ● 0.0% |
| Insurance | 1.2% | 0.0% | ▼ -1.2% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 70.4% | 70.5% | ● +0.0% |
| Healthcare Services | 20.6% | 21.1% | ▲ +0.5% |
| Industrial Products | 2.2% | 1.9% | ▼ -0.3% |
| Healthcare Equipment & Supplies | 1.3% | 1.5% | ▲ +0.2% |
| Chemicals & Petrochemicals | 1.3% | 1.1% | ▼ -0.2% |
| Retailing | 0.0% | 0.9% | ▲ +0.9% |
| Aerospace & Defense | 0.5% | 0.5% | ● -0.1% |
| Banks | 0.5% | 0.5% | ● -0.1% |
Comparing Jun 2026 → Jul 2026
| # | Stock | Sector | Weight (Jul 2026) |
|---|---|---|---|
| 1 | MedPlus Health Services Limited ₹2.30 Cr |
Retailing | 0.88% |
| # | Stock | Sector | Jun 2026 | Jul 2026 | Change |
|---|---|---|---|---|---|
| 1 | Divi's Laboratories Limited ₹20.94 Cr |
Pharmaceuticals & Biotechnology | 6.79% | 7.97% | +1.18% |
| 2 | Global Health Limited ₹7.82 Cr |
Healthcare Services | 2.01% | 2.98% | +0.97% |
| 3 | Mankind Pharma Limited ₹8.92 Cr |
Pharmaceuticals & Biotechnology | 2.84% | 3.39% | +0.55% |
| 4 | Torrent Pharmaceuticals Limited ₹12.72 Cr |
Pharmaceuticals & Biotechnology | 4.56% | 4.84% | +0.28% |
| 5 | Poly Medicure Limited ₹4.00 Cr |
Healthcare Equipment & Supplies | 1.28% | 1.52% | +0.24% |
| 6 | Syngene International Limited ₹1.60 Cr |
Healthcare Services | 0.39% | 0.61% | +0.22% |
| 7 | Alkem Laboratories Limited ₹7.68 Cr |
Pharmaceuticals & Biotechnology | 2.75% | 2.92% | +0.17% |
| 8 | Cohance Lifesciences Limited ₹7.99 Cr |
Pharmaceuticals & Biotechnology | 2.89% | 3.04% | +0.15% |
| 9 | Piramal Pharma Limited ₹3.33 Cr |
Pharmaceuticals & Biotechnology | 1.14% | 1.27% | +0.13% |
| 10 | Healthcare Global Enterprises Limited ₹3.18 Cr |
Healthcare Services | 1.09% | 1.21% | +0.12% |
| # | Stock | Sector | Jun 2026 | Jul 2026 | Change |
|---|---|---|---|---|---|
| 1 | Dr. Reddy's Laboratories Limited ₹11.58 Cr |
Pharmaceuticals & Biotechnology | 5.44% | 4.41% | -1.03% |
| 2 | Lupin Limited ₹7.41 Cr |
Pharmaceuticals & Biotechnology | 3.30% | 2.82% | -0.48% |
| 3 | Max Healthcare Institute Limited ₹13.26 Cr |
Healthcare Services | 5.41% | 5.05% | -0.36% |
| 4 | Aurobindo Pharma Limited ₹10.09 Cr |
Pharmaceuticals & Biotechnology | 4.10% | 3.84% | -0.26% |
| 5 | VENUS PIPES & TUBES LTD ₹1.83 Cr |
Industrial Products | 0.95% | 0.69% | -0.26% |
| 6 | Laurus Labs Limited ₹11.06 Cr |
Pharmaceuticals & Biotechnology | 4.40% | 4.21% | -0.19% |
| 7 | Aster DM Healthcare Limited ₹3.54 Cr |
Healthcare Services | 1.54% | 1.35% | -0.19% |
| 8 | Apollo Hospitals Enterprise Limited ₹15.89 Cr |
Healthcare Services | 6.22% | 6.05% | -0.17% |
| 9 | Cipla Limited ₹11.64 Cr |
Pharmaceuticals & Biotechnology | 4.60% | 4.43% | -0.17% |
| 10 | Fortis Healthcare Limited ₹7.32 Cr |
Healthcare Services | 2.94% | 2.79% | -0.15% |
38 stocks — Jul 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹34.86 Cr |
Pharmaceuticals & Biotechnology |
13.26%
|
|
| 2 |
₹20.94 Cr |
Pharmaceuticals & Biotechnology |
7.97%
|
|
| 3 |
₹15.89 Cr |
Healthcare Services |
6.05%
|
|
| 4 |
₹13.26 Cr |
Healthcare Services |
5.05%
|
|
| 5 |
₹12.72 Cr |
Pharmaceuticals & Biotechnology |
4.84%
|
|
| 6 |
₹11.64 Cr |
Pharmaceuticals & Biotechnology |
4.43%
|
|
| 7 |
₹11.58 Cr |
Pharmaceuticals & Biotechnology |
4.41%
|
|
| 8 |
₹11.06 Cr |
Pharmaceuticals & Biotechnology |
4.21%
|
|
| 9 |
₹10.09 Cr |
Pharmaceuticals & Biotechnology |
3.84%
|
|
| 10 |
₹8.92 Cr |
Pharmaceuticals & Biotechnology |
3.39%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.